Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Lipocine Inc.
OKLAHOMA CITY--(BUSINESS WIRE)--Nov 21, 2019--
Federman & Sherwood announces that on November 14, 2019, a class action lawsuit was filed in the United States District Court for the District of Utah against Lipocine Inc. (NASDAQ: LPCN). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is March 27, 2019 through November 8, 2019.
To learn how to participate in this action, please visit https://www.federmanlaw.com/blog/federman-sherwood-announces-the-filing-of-a-securities-class-action-lawsuit-against-lipocine-inc/
Plaintiff seeks to recover damages on behalf of all Lipocine Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, January 14, 2020 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005921/en/
CONTACT: Robin Hester
FEDERMAN & SHERWOOD
KEYWORD: OKLAHOMA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES
SOURCE: Federman & Sherwood
Copyright Business Wire 2019.
PUB: 11/21/2019 03:01 PM/DISC: 11/21/2019 03:01 PM